-- ブラジルを拠点とする金鉱採掘・開発会社であるセラビ・ゴールド(Serabi Gold plc、AIM: SRB、TSX: SBI)は、2026年第1四半期の生産実績と事業ハイライトを発表後、英国市場の午後早い時間帯に一時4%上昇した。 事業ハイライトとして、セラビは四半期金生産量が12,042オンスとなり、2025年第1四半期比で20%増加したことを挙げた。2026年3月31日時点の現金残高は6,440万米ドルで、2025年12月31日時点の4,920万米ドルから増加した。同社は現在無借金状態であり、当四半期中に530万米ドルを返済したと発表した。 その他の注目すべき点として、セラビ社はパリト複合施設に4基目のボールミル設置を開始しました。このボールミルは2026年第4四半期に稼働開始予定で、2027年には年間処理量が33万トンに増加する見込みです。また、12ヶ月間の鉱石選別作業の成功を受け、同社はコリンガ鉱山において、選択的オープンストーピングから機械化されたサブレベルストーピングへの移行を進めています。コリンガ鉱山は現在、2027年1月29日に期限切れとなる3年間のGUIAライセンスの下で操業しています。 セラビ社のCEO、マイク・ホジソン氏は次のように述べています。「両鉱山とも順調に操業しています。鉱石選別機は2025年の年間生産量記録達成に大きく貢献しました。また、コリンガ鉱脈の地質的な連続性が良好であったことも相まって、選択的オープンストーピングからより機械化されたサブレベルオープンストーピングへの移行が可能となり、コスト、生産量、安全性の面で多くのメリットが得られました。コリンガ鉱山の機械化は2026年第3四半期までに完了する予定です。」セラビ社の株価は昨日、カナダ市場で3.8%上昇した。
Related Articles
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.
Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.